Please note
This trial is no longer recruiting patients. We hope to add results when they are available.
Breast cancer
Closed
Phase 3
This study is for people with breast cancer that has come back in the area where it was first found, or that has spread elsewhere in the body.
It is open to men and women whose breast cancer cells have:
receptors for oestrogen or progesterone (hormone receptor positive)
low or no amounts of HER2 (HER2 negative breast cancer)
Also, they have not had any hormone therapy for their advanced breast cancer.
Recruitment start: 1 March 2017
Recruitment end: 30 November 2017
Please note: In order to join a trial you will need to discuss it with your doctor, unless otherwise specified.
Dr Alistair Ring
Novartis
Last reviewed: 2 March 2018
CRUK internal database number: 14412